Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Quaggin to Lead Cardiovascular Research Institute, Division of Nephrology
Uncategorized

Quaggin to Lead Cardiovascular Research Institute, Division of Nephrology

By medwebJun 19, 2012
Share
Facebook Twitter Email

Susan Quaggin, MD, an international authority in the field of nephrology, will join Northwestern University Feinberg School of Medicine as the Charles Horace Mayo Professor of Medicine, and serve as director of the Feinberg Cardiovascular Research Institute (FCVRI) and chief of the Division of Nephrology, effective January 2013.

“As one of the world’s most dynamic and creative investigators in the fields of nephrology and vascular biology, Dr. Quaggin will make an outstanding addition to the Feinberg faculty,” said Eric G. Neilson, MD, Feinberg’s vice president for medical affairs and Lewis Landsberg Dean. “Her career has been built around the pursuit of novel genetic methods to understand the complexity of capillary formation in health and disease, and her leadership will undoubtedly shine an international spotlight on the division and our cardiovascular research institute.”

A graduate from the Faculty of Medicine at the University of Toronto, Quaggin received her specialty degree in internal medicine in 1992. She completed subspecialty training in nephrology at the University of Toronto and did a post-doctoral fellowship at Yale University, where she studied the genetic basis of kidney development. In 1997, she returned to Toronto for a second post-doctoral fellowship in complex mouse genetics in the renowned laboratory of Janet Rossant, and then went on to establish her own stellar program in vascular biology. She comes to Feinberg following long tenure as a scholar and professor of medicine at Toronto, where she currently holds the Gabor-Zellerman Chair in Medicine. A senior scientist with the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, she also is a practicing nephrologist at St. Michael’s Hospital.

“Dr. Quaggin’s arrival extends the impact and competitiveness of Feinberg, and her perspectives will reinvigorate the FCVRI and take research orientation in some new and exciting directions,” said Douglas Vaughan, MD, Department of Medicine chair. “Her leadership will be a magnet for future talent, and I expect she will immediately accelerate and grow our basic research in nephrology,”

Quaggin’s major research focus is on the genetic and molecular pathways that establish and maintain complex capillary structures, particularly those forming the renal glomerular filtration barrier — a highly selective filter that separates circulating blood from the urinary space in the kidney. She has chaired many international research meetings and review panels and is the rising program chair for the 2014 national meeting of the American Society of Nephrology. The recipient of the 2009 Medal for Excellence from the Kidney Foundation of Canada, she is also deputy editor of the Journal of the American Society of Nephrology, the leading kidney journal in the world, serves on the editorial boards of several other journals, and is an elected councilor of the American Society for Clinical Investigation and the International Society of Nephrology. Quaggin was recently named an Academy of Finland Distinguished Professor.

Research
Share. Facebook Twitter Email

Related Posts

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Comments are closed.

Latest News

Epigenetic Biomarkers Predict CVD Risk

Jun 28, 2022

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220617_NM_0434
20220617_NM_0858
20220617_NM_0643
20220617_NM_0835
20220617_NM_0544
20220617_NM_0450
20220617_NM_0790
20220617_NM_0811
20220617_NM_0851
20220617_NM_0696
20220617_NM_0779
20220617_NM_0838

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.